<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5C237E7F-364C-491F-A592-A4F6AB37107C"><gtr:id>5C237E7F-364C-491F-A592-A4F6AB37107C</gtr:id><gtr:name>Seattle Biomedical Research Institute</gtr:name><gtr:address><gtr:line1>Seattle Biomedical Research Institute</gtr:line1><gtr:line2>4 Nickerson Street</gtr:line2><gtr:line3>Seattle</gtr:line3><gtr:postCode>98109-1651</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/0C8A61C0-41B2-4A21-B0DB-08F235F18F0B"><gtr:id>0C8A61C0-41B2-4A21-B0DB-08F235F18F0B</gtr:id><gtr:name>Uni of South Bohemia Ceske Budejovice</gtr:name><gtr:address><gtr:line1>University Ceske Budejovice</gtr:line1><gtr:line2>Branisovska 31</gtr:line2><gtr:postCode>CZ-37005</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Biological Sciences</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5C237E7F-364C-491F-A592-A4F6AB37107C"><gtr:id>5C237E7F-364C-491F-A592-A4F6AB37107C</gtr:id><gtr:name>Seattle Biomedical Research Institute</gtr:name><gtr:address><gtr:line1>Seattle Biomedical Research Institute</gtr:line1><gtr:line2>4 Nickerson Street</gtr:line2><gtr:line3>Seattle</gtr:line3><gtr:postCode>98109-1651</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/0C8A61C0-41B2-4A21-B0DB-08F235F18F0B"><gtr:id>0C8A61C0-41B2-4A21-B0DB-08F235F18F0B</gtr:id><gtr:name>Uni of South Bohemia Ceske Budejovice</gtr:name><gtr:address><gtr:line1>University Ceske Budejovice</gtr:line1><gtr:line2>Branisovska 31</gtr:line2><gtr:postCode>CZ-37005</gtr:postCode><gtr:region>Outside UK</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/DDD14154-81FB-417E-81AA-AAEA066ECA04"><gtr:id>DDD14154-81FB-417E-81AA-AAEA066ECA04</gtr:id><gtr:name>The Wellcome Trust  Sanger Institute</gtr:name><gtr:address><gtr:line1>Wellcome Trust Genome Campus</gtr:line1><gtr:line2>Hinxton</gtr:line2><gtr:postCode>CB10 1SA</gtr:postCode><gtr:region>East of England</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F724BB81-CAD8-43A7-B2C0-394CD9DE4639"><gtr:id>F724BB81-CAD8-43A7-B2C0-394CD9DE4639</gtr:id><gtr:name>University of California, San Diego</gtr:name><gtr:address><gtr:line1>9500 Gilman Drive</gtr:line1><gtr:line4>La Jolla</gtr:line4><gtr:line5>CA 92093</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/68D0E3C9-9246-4CFC-B5E9-48584CF82993"><gtr:id>68D0E3C9-9246-4CFC-B5E9-48584CF82993</gtr:id><gtr:name>University of Manchester</gtr:name><gtr:address><gtr:line1>Oxford Road</gtr:line1><gtr:city>Manchester</gtr:city><gtr:postCode>M13 9PL</gtr:postCode><gtr:region>North West</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/0F86F02A-0450-457B-9736-31B44CCF6D09"><gtr:id>0F86F02A-0450-457B-9736-31B44CCF6D09</gtr:id><gtr:firstName>Achim</gtr:firstName><gtr:otherNames>Christian</gtr:otherNames><gtr:surname>Schnaufer</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600129"><gtr:id>ED7B5209-115F-42EA-9CC9-F482F034B53D</gtr:id><gtr:title>Mitochondrial function in bloodstream stage trypanosomes</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600129</gtr:grantReference><gtr:abstractText>Trypanosomatids are unicellular parasites and the causative agents of diseases with devastating consequences for public health and economy in the developing world, such as African sleeping sickness, Leishmaniasis, and Chagas? disease. Most available drugs are increasingly ineffective due to toxicity and development of resistance. This project will characterize the role of the mitochondrion - a cell organelle - in the disease-causing stage of the parasite, thereby identifying new drug targets and helping to understand the action of existing drugs. We will accomplish this with the help of advanced genetic methods that allow the temporary inactivation of certain mitochondrial enzymes. The effects of enzyme inactivation on the physiology of the parasite will then be investigated.</gtr:abstractText><gtr:technicalSummary>Trypanosomatids are protozoan pathogens that cause a variety of diseases in man and livestock. Most drugs are increasingly ineffective due to toxicity and development of resistance. Mitochondrial gene expression and function are essential for survival of the parasite - despite the absence of oxidative phosphorylation in the disease-causing bloodsteam form - and may represent powerful targets for new drugs. However, mitochondrial biology in the bloodstream stage is poorly understood and the essential function of the organelle for the parasite is not known. This project will test the hypothesis that respiratory complexes I (NADH:ubiquinone oxidoreductase) and/or V (ATP synthase) are required for viability of the bloodsteam form of the parasite and that essential components of one or both of these complexes are mitochondrially expressed. This hypothesis is based on evidence that these complexes are active in the bloodsteam form and on the in silico identification of mitochondrial genes encoding putative subunits of these complexes. (1) Complexes I and V will be inactivated by silencing the expression of essential nuclearly encoded subunits using RNAi and the effects on cell growth and on parameters of mitochondrial function such as ATP levels, respiration, membrane potential, and protein import will be examined. (2) The hypothesis will be tested that mitochondrial genes encode subunits of respiratory complexes I and V by identifying the interaction partners of the gene products in vivo. Protein purification and identification will be achieved through affinity tagging and mass spectrometry. (3) The requirement for RNA editing and activities identified in (1) will be determined in dyskinetoplastic trypanosomes, which have lost their mitochondrial DNA and may thus indicate potential routes for drug resistance. This will be achieved through gene inactivation of functionally essential subunits. These studies will provide novel insights into mitochondrial function in trypanosomatids, validate new drug targets, and assess the potential for resistance to drugs targeting mitochondrial function.</gtr:technicalSummary><gtr:fund><gtr:end>2013-04-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2008-05-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1052146</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Seattle Biomedical Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Trypanosoma evansi sequencing project</gtr:description><gtr:id>40E91823-DF47-43B7-9214-DAC1AF3A22D8</gtr:id><gtr:impact>The genome of Trypanosoma evansi STIB810 has been sequenced and analyzed and been deposited in public databases. A manuscript is in press.</gtr:impact><gtr:outcomeId>0EB68756CD2-2</gtr:outcomeId><gtr:partnerContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing</gtr:partnerContribution><gtr:piContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing, molecular biology</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, San Diego (UCSD)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>REL1 drug development collaboration with R. Amaro and M. Greaney</gtr:description><gtr:id>2EBC426A-542F-4D52-BF88-EB087A6286EE</gtr:id><gtr:impact>We have identified a number of micromolar REL1 inhibitors and are in the process of testing more. Some of these inhibitors were presented in publication (PMIDs 18981420 and 20808768). Building on preliminary results as well as results published in the above study, a grant to further develop and expand this project has been awarded by the Wellcome Trust.</gtr:impact><gtr:outcomeId>BDBCAAC330C-1</gtr:outcomeId><gtr:partnerContribution>Collaborators identify and synthesize candidate inhibitors for REL1, a trypanosome enzyme that we study. Joint grant applications are in progress.</gtr:partnerContribution><gtr:piContribution>REL1 inhibitor candidates identified by virtual screening or synthesized in our collaborator's labs are tested in our lab in in vitro and in vivo assays. The discussion of results and planning of next steps involves all collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Seattle Biomedical Research Institute</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Analysis of respiratory complexes in Trypanosoma brucei</gtr:description><gtr:id>123F2BFD-C91C-464E-B7C8-311B49FFE8FF</gtr:id><gtr:impact>Data have been presented at several international meetings. One manuscript has been published and one is in preparation.</gtr:impact><gtr:outcomeId>722B7814C06-1</gtr:outcomeId><gtr:partnerContribution>The collaboration between the Parsons lab at SBRI and our lab investigates the function of respiratory complexes in Trypanosoma brucei. Data are generated and analyzed in a collaborative way in both labs. A manuscript is in preparation.</gtr:partnerContribution><gtr:piContribution>Data generation and analysis.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of South Bohemia</gtr:collaboratingOrganisation><gtr:country>Czech Republic</gtr:country><gtr:department>Institute of Parasitology</gtr:department><gtr:description>Trypanosoma evansi sequencing project</gtr:description><gtr:id>25043E7E-9452-4C38-81E7-29D46B1CDC4E</gtr:id><gtr:impact>The genome of Trypanosoma evansi STIB810 has been sequenced and analyzed and been deposited in public databases. A manuscript is in press.</gtr:impact><gtr:outcomeId>0EB68756CD2-1</gtr:outcomeId><gtr:partnerContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing</gtr:partnerContribution><gtr:piContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing, molecular biology</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Manchester</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Chemistry Manchester</gtr:department><gtr:description>REL1 drug development collaboration with R. Amaro and M. Greaney</gtr:description><gtr:id>C2A30D8A-7632-401D-BD16-B8B2B68B0759</gtr:id><gtr:impact>We have identified a number of micromolar REL1 inhibitors and are in the process of testing more. Some of these inhibitors were presented in publication (PMIDs 18981420 and 20808768). Building on preliminary results as well as results published in the above study, a grant to further develop and expand this project has been awarded by the Wellcome Trust.</gtr:impact><gtr:outcomeId>BDBCAAC330C-2</gtr:outcomeId><gtr:partnerContribution>Collaborators identify and synthesize candidate inhibitors for REL1, a trypanosome enzyme that we study. Joint grant applications are in progress.</gtr:partnerContribution><gtr:piContribution>REL1 inhibitor candidates identified by virtual screening or synthesized in our collaborator's labs are tested in our lab in in vitro and in vivo assays. The discussion of results and planning of next steps involves all collaborators.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Sanger Institute</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Trypanosoma evansi sequencing project</gtr:description><gtr:id>660AAC32-7E27-405B-949D-CC8B8169B505</gtr:id><gtr:impact>The genome of Trypanosoma evansi STIB810 has been sequenced and analyzed and been deposited in public databases. A manuscript is in press.</gtr:impact><gtr:outcomeId>0EB68756CD2-3</gtr:outcomeId><gtr:partnerContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing</gtr:partnerContribution><gtr:piContribution>Bioinformatics analyses, data interpretation, preparation of reagents, genome sequencing, molecular biology</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Dourine Workshop</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>EB08B4B7-A961-4AFB-9B74-EF945D1E2083</gtr:id><gtr:impact>50-70 students, veterinary scientists and doctors, and policymakers attended a workshop on dourine (an infectious disease in horses).

The workshop took place in Teramo, Italy, 18-19 April 2012. 

The title of my presentation was &amp;quot;Kinetoplastids without a kinetoplast: how Trypanosoma equiperdum and T. evansi survive without mitochondrial DNA&amp;quot;

The training course offered the opportunity:
- to present activities, research projects and experiences carried out by the National Reference Centre for Foreign Animal Diseases of Istituto G. Caporale (ICT) focused on Dourine diagnosis;
- to deepen surveillance and control strategies adopted in Italy and in Europe;
- to share experiences at national and international level.
This course aims at providing Italian Official Veterinarians belonging to the National Competent Authority, the Regional Veterinary Services, Istituti Zooprofilattici Sperimentali and Research Institutions, with the necessary tools to recognise, diagnose and control Dourine disease.</gtr:impact><gtr:outcomeId>FZX1nsJYZBv</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1876</gtr:amountPounds><gtr:country>Global</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>GSK Tres Cantos Open Lab Foundation</gtr:description><gtr:end>2014-12-02</gtr:end><gtr:fundingOrg>GlaxoSmithKline (GSK)</gtr:fundingOrg><gtr:fundingRef>TC054</gtr:fundingRef><gtr:id>48C8F71F-2007-4BD4-87F8-7F4FB84FB3AF</gtr:id><gtr:outcomeId>YKXNyaTNE8u</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2013-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>350000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Project Grant</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>9EF4373D-CF81-4062-9877-8C02E24CD412</gtr:id><gtr:outcomeId>DP8JPijvyMQ0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>USD</gtr:currCode><gtr:currCountryCode>Ecuador</gtr:currCountryCode><gtr:currLang>es_EC</gtr:currLang><gtr:description>NIH R21 High Throughput Molecular Screening</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>National Institute of Allergy and Infectious Diseases (NIAID)</gtr:fundingOrg><gtr:fundingRef>R21 NS06173301</gtr:fundingRef><gtr:id>B7F4A94D-939D-49CB-A7AD-5DA495324BFC</gtr:id><gtr:outcomeId>UMvsn2wB4Ro</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-03-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28600</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>SULSA High Throughput Screening Fund/Scottish Universities Life Sciences Alliance, High Throughput Screening Fund</gtr:description><gtr:end>2014-06-02</gtr:end><gtr:fundingOrg>Scottish Universities Life Sciences Alliance (SULSA)</gtr:fundingOrg><gtr:id>C560C5FB-C485-491A-A2DC-D1148829C149</gtr:id><gtr:outcomeId>facLdcM7chb0</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-11-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Ad hoc advisory group on non-tsetse transmitted animal trypanosomoses</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>F478B678-B74F-44E2-AFCF-9AA890250FFC</gtr:id><gtr:impact>The discussions of the workgroup result in updated policies issued by OIE on diagnosis and treatment of surra and dourine.</gtr:impact><gtr:outcomeId>f757S5vXdKd</gtr:outcomeId><gtr:type>Participation in a advisory committee</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Solexa and 454 whole genome shotgun sequencing of Trypanosoma evansi strain STIB805.</gtr:description><gtr:id>42853358-B44B-42A2-8F02-96F5F3BC408A</gtr:id><gtr:impact>Analysis of the T. evansi genome will provide insight into the unique biology of this mechanically transmitted animal pathogen.</gtr:impact><gtr:outcomeId>E78F39092E4</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Trypanosoma evansi STIB805 genome sequence</gtr:title><gtr:type>Biological samples</gtr:type><gtr:url>http://www.tritrypdb.org</gtr:url><gtr:yearFirstProvided>2009</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Solexa whole genome sequencing data of wild type and dyskinetoplastic strains of T. brucei EATRO 164.</gtr:description><gtr:id>A1CC2224-450B-4E94-926C-9FD416078911</gtr:id><gtr:impact>Comparison of the wild type and dyskinetoplastic (dk) strains will provide insight into the compensatory mechanisms that allow the dk form to survive without mitochondrial DNA.</gtr:impact><gtr:outcomeId>A812B7CA359</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Trypanosoma brucei EATRO164 wt and dk genome sequence</gtr:title><gtr:type>Biological samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A transgenic trypanosome cell line engineered to survive without mitochondrial DNA.</gtr:description><gtr:id>73F9E4D7-B42A-4E26-9995-3D9B456857E4</gtr:id><gtr:impact>This cell line allows us to study the function of mitochondrial DNA in trypanosomes and to carry out differential drug and RNAi screens.</gtr:impact><gtr:outcomeId>W2eHUHikF2t</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>T.brucei bf427 Dk</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Custom anti-peptide antibody for subunit alpha of the mitochondrial ATP synthase complex.</gtr:description><gtr:id>3103DC49-A482-4550-918E-38BE89E4300D</gtr:id><gtr:impact>This antibody allows us to study the function of the mitochondrial ATP synthase complex.</gtr:impact><gtr:outcomeId>a1iwAinJ9pn</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ATPase subunit alpha antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A number of RNA ligase inhibitors were identified among compounds that are already commercially available. These results were published.</gtr:description><gtr:id>93538EAD-3644-4385-AC68-78F523C430E6</gtr:id><gtr:impact>Companies selling these compounds used our published data for advertising purposes.</gtr:impact><gtr:outcomeId>EehWrwYTmvR</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>RNA ligase inhibitors</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>http://pubchem.ncbi.nlm.nih.gov/assay/assay.cgi?aid=1117282</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Custom anti-peptide antibody for subunit gamma of the mitochondrial ATP synthase complex.</gtr:description><gtr:id>1A4F15E9-3F86-404A-98EE-13D863A9B0BC</gtr:id><gtr:impact>This antibody allows us to study the function of the mitochondrial ATP synthase complex.</gtr:impact><gtr:outcomeId>nvBmuJsaxN3</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>ATPase subunit gamma antibody</gtr:title><gtr:type>Antibody</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>An activity-based enzymatic assay for RNA editing ligase (that can also used for other RNA or DNA ligases) allowing high-throughput screening of chemical libraries.</gtr:description><gtr:id>EFD33AC3-EAC0-4C89-B2B8-BEACF1CC6964</gtr:id><gtr:impact>Developing this assay was key in obtaining funding from SULSA and the Wellcome Trust for drug discovery projects. The assay was used to identify novel REL1 inhibitors.</gtr:impact><gtr:outcomeId>QE3TEodtLhu</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>RNA ligase high throughput assay</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>61EBC88F-DF2A-436E-AE54-9C2490A49AC7</gtr:id><gtr:title>A novel high-throughput activity assay for the Trypanosoma brucei editosome enzyme REL1 and other RNA ligases.</gtr:title><gtr:parentPublicationTitle>Nucleic acids research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/51b5122ea6508faa5a6f8f8e60be9241"><gtr:id>51b5122ea6508faa5a6f8f8e60be9241</gtr:id><gtr:otherNames>Zimmermann S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0305-1048</gtr:issn><gtr:outcomeId>56cdbbfb800877.06200191</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>715081F0-72B6-4A3C-9DA2-664E180F29E0</gtr:id><gtr:title>Trypanosomal TAC40 constitutes a novel subclass of mitochondrial ?-barrel proteins specialized in mitochondrial genome inheritance.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/890e48ce325822f069f693971363b7f9"><gtr:id>890e48ce325822f069f693971363b7f9</gtr:id><gtr:otherNames>Schnarwiler F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>546296f916b513.53660704</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F4826178-1C78-44B1-BF87-29A214800471</gtr:id><gtr:title>Evolution of dyskinetoplastic trypanosomes: how, and how often?</gtr:title><gtr:parentPublicationTitle>Trends in parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b418cdde2835dda8be62151a05d8fa7c"><gtr:id>b418cdde2835dda8be62151a05d8fa7c</gtr:id><gtr:otherNames>Schnaufer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1471-4922</gtr:issn><gtr:outcomeId>VDCbXkQecni</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4AFEFE7D-EED5-4939-878B-4EE9BFF19E33</gtr:id><gtr:title>Enigmatic presence of mitochondrial complex I in Trypanosoma brucei bloodstream forms.</gtr:title><gtr:parentPublicationTitle>Eukaryotic cell</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/358f3e69b0e4f741379f48667b0da379"><gtr:id>358f3e69b0e4f741379f48667b0da379</gtr:id><gtr:otherNames>Surve S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1535-9786</gtr:issn><gtr:outcomeId>JKWXqudvoGA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>64C4DCA2-B050-4B55-B1C9-C4D7751CF371</gtr:id><gtr:title>In situ structure of trypanosomal ATP synthase dimer reveals a unique arrangement of catalytic subunits.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/68af5a1718985b82c34104f86fa76341"><gtr:id>68af5a1718985b82c34104f86fa76341</gtr:id><gtr:otherNames>M?hleip AW</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>58c0447dc37d39.45468454</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BABDBC4D-CD56-4AF6-AD79-588DD37558EE</gtr:id><gtr:title>Novel naphthalene-based inhibitors of Trypanosoma brucei RNA editing ligase 1.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/487da332cd28b40450616a1257e42821"><gtr:id>487da332cd28b40450616a1257e42821</gtr:id><gtr:otherNames>Durrant JD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>EK4NwXMvV7w</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1888211-7062-4F52-9F6B-5BC1D8884E38</gtr:id><gtr:title>PNT1 Is a C11 Cysteine Peptidase Essential for Replication of the Trypanosome Kinetoplast.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f511a24050a7b25afe70315f2bc7ff8b"><gtr:id>f511a24050a7b25afe70315f2bc7ff8b</gtr:id><gtr:otherNames>Grewal JS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>585d453f4a0824.44591788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AB83323E-B0F9-4DA9-BFCC-FF149FF9CE48</gtr:id><gtr:title>How to survive and thrive without mitochondrial DNA: A protozoan's guide to ATP synthase modification</gtr:title><gtr:parentPublicationTitle>Biochimica et Biophysica Acta (BBA) - Bioenergetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f781177af8c597b1952bf47d7f5671a4"><gtr:id>f781177af8c597b1952bf47d7f5671a4</gtr:id><gtr:otherNames>Gould M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_55f944944a7e6a27</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>36B945B8-26D6-4234-9E92-675E44B5DE7F</gtr:id><gtr:title>Independence from Kinetoplast DNA maintenance and expression is associated with multidrug resistance in Trypanosoma brucei in vitro.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3890eeafc968a4923547cddc25e478f6"><gtr:id>3890eeafc968a4923547cddc25e478f6</gtr:id><gtr:otherNames>Gould MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_540e148e148fcfcd0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>80E44CAB-6E44-4D2C-B5F7-D66C71D5E0E0</gtr:id><gtr:title>Functional analysis of respiratory complex I (NADH:ubiquinone oxidoreductase) in the early-branching eukaryote Trypanosoma brucei</gtr:title><gtr:parentPublicationTitle>Biochimica et Biophysica Acta (BBA) - Bioenergetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b418cdde2835dda8be62151a05d8fa7c"><gtr:id>b418cdde2835dda8be62151a05d8fa7c</gtr:id><gtr:otherNames>Schnaufer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:outcomeId>doi_55f944944a75aa48</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F96D09FF-2FC4-47BC-B0C6-CF1ED2A69D57</gtr:id><gtr:title>Genome and phylogenetic analyses of Trypanosoma evansi reveal extensive similarity to T. brucei and multiple independent origins for dyskinetoplasty.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e6f649c2e890e6b29223f6af5fd41fd"><gtr:id>9e6f649c2e890e6b29223f6af5fd41fd</gtr:id><gtr:otherNames>Carnes J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>doi_55faa1aa1922db7b</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>496EAA74-3D3F-42BF-AC12-3582A191E3A6</gtr:id><gtr:title>NADH dehydrogenase of Trypanosoma brucei is important for efficient acetate production in bloodstream forms.</gtr:title><gtr:parentPublicationTitle>Molecular and biochemical parasitology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dfa9bbd9b14657199a0051126f9e500a"><gtr:id>dfa9bbd9b14657199a0051126f9e500a</gtr:id><gtr:otherNames>Surve SV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0166-6851</gtr:issn><gtr:outcomeId>585d34c967b2b7.10530996</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>35F5659F-0DC2-4B0A-B265-3468E9B9F759</gtr:id><gtr:title>Single point mutations in ATP synthase compensate for mitochondrial genome loss in trypanosomes.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785ba76b09bce7acc76e8b3d8a44f123"><gtr:id>785ba76b09bce7acc76e8b3d8a44f123</gtr:id><gtr:otherNames>Dean S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>pm_13159_29_23959897</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4A6B8924-F5E5-4342-84FB-D19E33CB85D3</gtr:id><gtr:title>Cyclic AMP effectors in African trypanosomes revealed by genome-scale RNA interference library screening for resistance to the phosphodiesterase inhibitor CpdA.</gtr:title><gtr:parentPublicationTitle>Antimicrobial agents and chemotherapy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3890eeafc968a4923547cddc25e478f6"><gtr:id>3890eeafc968a4923547cddc25e478f6</gtr:id><gtr:otherNames>Gould MK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0066-4804</gtr:issn><gtr:outcomeId>pm_13159_29_23877697</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600129</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CDB856E6-DF2D-4D96-88BD-1CC96FE277EF</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.2  Factors relating to physical environment</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>